Anemia, Allogenic Blood Transfusion, and Immunomodulation in the Critically Ill
- 1 January 2005
- Vol. 127 (1) , 295-307
- https://doi.org/10.1378/chest.127.1.295
Abstract
No abstract availableKeywords
This publication has 129 references indexed in Scilit:
- Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactionsTransfusion and Apheresis Science, 2004
- The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States*Critical Care Medicine, 2004
- Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrenceBritish Journal of Surgery, 2001
- DONOR-SPECIFIC TRANSFUSIONS HAVE LONG-TERM BENEFICIAL EFFECTS FOR HUMAN RENAL ALLOGRAFTS1Transplantation, 1995
- Descriptive analysis of critical care units in the United StatesCritical Care Medicine, 1993
- Clostridial sepsis with massive intravascular hemolysis: Rapid diagnosis and successful treatmentIntensive Care Medicine, 1992
- COSTIMULATORY SIGNALS NECESSARY FOR INDUCTION OF T CELL PROLIFERATIONTransplantation, 1990
- Phlebotomy for Diagnostic Laboratory Tests in AdultsNew England Journal of Medicine, 1986
- Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow TransplantationNew England Journal of Medicine, 1986
- Risk of Infection after Penetrating Abdominal TraumaNew England Journal of Medicine, 1984